Amylx Pharmaceuticals Inc vs AST SpaceMobile Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while AST SpaceMobile Inc trades at $71.88 (market cap $20.54B). The key difference: AST SpaceMobile Inc is far larger — about 7.8× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, AST SpaceMobile Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | ASTS | |
|---|---|---|
Market Cap | $2.64B | $20.54B |
Sector | Health | Media |
52-Week High | $24.19 | $133.09 |
52-Week Low | $7.82 | $36.91 |
Enterprise Value | $2.39B | $21.25B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.
Read more on ASTS →